Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

shRNA Mediated RHOXF1 Silencing Influences Expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 Cell Lines

  • Ghafouri-Fard, Soudeh (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences) ;
  • Abdollahi, Davood Zare (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences) ;
  • Omrani, Mirdavood (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences) ;
  • Azizi, Faezeh (Department of Medical Genetics, Shahid Beheshti University of Medical Sciences)
  • Published : 2012.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

RHOXF1 has been shown to be expressed in embryonic stem cells, adult germline stem cells and some cancer lines. It has been proposed as a candidate gene to encode transcription factors regulating downstream genes in the human testis with antiapoptotic effects. Its expression in cancer cell lines has implied a similar role in the process of tumorigenesis. The human breast cancer cell lines MDA-MB-231 and MCF-7 were cultured in DMEM medium and transfected with a pGFP-V-RS plasmid bearing an RHOXF1 specific shRNA. Quantitative real-time RT-PCR was performed for RHOXF1, CASP8, BCL2 and HPRT genes. Decreased RHOXF1 expression was confirmed in cells after transfection. shRNA knock down of RHOXF1 resulted in significantly decreased BCL2 expression in both cell lines but no change in CASP8 expression. shRNA targeting RHOXF1 was shown to specifically mediate RHOXF1 gene silencing, so RHOXF1 can mediate transcriptional activation of the BCL2 in cancers and may render tumor cells resistant to apoptotic cell death induced by anticancer therapy. shRNA mediated knock down of RHOXF1 can be effective in induction of apoptotic pathway in cancer cells via BCL2 downregulation, so it can have potential therapeutic utility for human breast cancer.

Keywords

References

  1. Costa FF, Le Blanc K, Brodin B (2007). Concise review: cancer/ testis antigens, stem cells, and cancer. Stem Cells, 25, 707-11.
  2. Fan Y, Melhem MF, Chaillet JR (1999). Forced expression of the homeobox-containing gene Pem blocks differentiation of embryonic stem cells. Dev Biol, 210, 481-96. https://doi.org/10.1006/dbio.1999.9279
  3. Geserick C, Weiss B, Schleuning WD, Haendler B (2002). OTEX, an androgen-regulated human member of the pairedlike class of homeobox genes. Biochem J, 366, 367-75. https://doi.org/10.1042/bj20020399
  4. Hofmann O, Caballero OL, Stevenson BJ, et al (2008). Genomewide analysis of cancer/testis gene expression. Proc Natl Acad Sci USA, 105, 20422-27. https://doi.org/10.1073/pnas.0810777105
  5. Hu Z, Dandekar D, O'Shaughnessy PJ, et al (2010). Androgeninduced Rhox homeobox genes modulate the expression of AR-regulated genes. Mol Endocrinol, 24, 60-75. https://doi.org/10.1210/me.2009-0303
  6. Maclean JA, Chen MA, Wayne CM, et al (2005). Rhox: a new homeobox gene cluster. Cell, 120, 369-82. https://doi.org/10.1016/j.cell.2004.12.022
  7. MacLean JA, Wilkinson MF (2010). The Rhox genes. Reproduction, 140, 195-213. https://doi.org/10.1530/REP-10-0100
  8. McGinnis W, Krumlauf R (1992). Homeobox genes and axial patterning. Cell, 68, 283-302. https://doi.org/10.1016/0092-8674(92)90471-N
  9. Saeki K, Yuo A, Okuma E, et al (2000). Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ, 7, 1263-9. https://doi.org/10.1038/sj.cdd.4400759
  10. Shah N, Sukumar S (2010). The Hox genes and their roles in oncogenesis. Nat Rev Cancer, 10, 361-71. https://doi.org/10.1038/nrc2826
  11. Shipitsin M, Polyak K (2008). The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest, 88, 459-63. https://doi.org/10.1038/labinvest.2008.14
  12. Wayne CM, MacLean JA, Cornwall G, Wilkinson MF (2002). Two novel human X-linked homeobox genes, hPEPP1 and hPEPP2, selectively expressed in the testis. Gene, 301, 1-11. https://doi.org/10.1016/S0378-1119(02)01087-9
  13. Weigel RJ, deConinck EC (1993). Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res, 53, 3472-4.
  14. Wilkinson MF, Kleeman J, Richards J, MacLeod CL (1990). A novel oncofetal gene is expressed in a stage-specific manner in murine embryonic development. Dev Biol, 141, 451-5. https://doi.org/10.1016/0012-1606(90)90400-D
  15. Wu X, Chen H, Parker B, et al (2006). HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res, 66, 9527-34. https://doi.org/10.1158/0008-5472.CAN-05-4470
  16. Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV (2010). Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. BMC Cancer, 10, 32. https://doi.org/10.1186/1471-2407-10-32
  17. Yang J, Liu X, Bhalla K, et al (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 275, 1129-32. https://doi.org/10.1126/science.275.5303.1129
  18. Yang L, Cao Z, Yan H, Wood WC (2003). Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res, 63, 6815-24.
  19. Yang S, Liu J, Thor AD, Yang X (2007). Caspase expression profile and functional activity in a panel of breast cancer cell lines. Oncol Rep, 17, 1229-35.
  20. Zhang J, Huang S, Zhang H, et al (2010). Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA. Int J Cancer, 126, 2229-39.
  21. Zhang Y, Huang Q, Cheng JC, et al (2010). Homeobox A7 increases cell proliferation by up-regulation of epidermal growth factor receptor expression in human granulosa cells. Reprod Biol Endocrinol, 8, 61. https://doi.org/10.1186/1477-7827-8-61
  22. Zheng Y, Rodrik V, Toschi A, et al (2006). Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem, 281, 15862-8. https://doi.org/10.1074/jbc.M600660200

Cited by

  1. Expression Analysis of Two Cancer-testis Genes, FBXO39 and TDRD4, in Breast Cancer Tissues and Cell Lines vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6625
  2. Lactobacillus acidophilus and Lactobacillus crispatus Culture Supernatants Downregulate Expression of Cancer-testis Genes in the MDA-MB-231 Cell Line vol.15, pp.10, 2014, https://doi.org/10.7314/APJCP.2014.15.10.4255
  3. Are So-Called Cancer-Testis Genes Expressed Only in Testis? vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7703
  4. Bladder Cancer Biomarkers: Review and Update vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2395
  5. Expression of Cancer-Testis Antigens in Stem Cells: Is it a Potential Drawback or an Advantage in Cancer Immunotherapy vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.3079
  6. Effects of Ezrin and Heat Shock Protein 70 on Apoptosis and Proliferation of Human Osteosarcoma Cells vol.7, pp.3, 2015, https://doi.org/10.1111/os.12186
  7. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy vol.9, pp.12, 2017, https://doi.org/10.2217/imt-2017-0083
  8. Melanoma: a prototype of cancer-testis antigen-expressing malignancies vol.9, pp.13, 2017, https://doi.org/10.2217/imt-2017-0091
  9. Cancer–testis genes as candidates for immunotherapy in breast cancer vol.6, pp.2, 2014, https://doi.org/10.2217/imt.13.165
  10. New York esophageal squamous cell carcinoma-1 and cancer immunotherapy vol.7, pp.4, 2015, https://doi.org/10.2217/imt.15.3